Incannex Healthcare (IXHL) Competitors $0.23 +0.03 (+16.80%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IXHL vs. ABVC, NRSN, CASI, KALA, QTTB, ENLV, XFOR, FNCH, SXTC, and OVIDShould you be buying Incannex Healthcare stock or one of its competitors? The main competitors of Incannex Healthcare include ABVC BioPharma (ABVC), NeuroSense Therapeutics (NRSN), CASI Pharmaceuticals (CASI), KALA BIO (KALA), Q32 Bio (QTTB), Enlivex Therapeutics (ENLV), X4 Pharmaceuticals (XFOR), Finch Therapeutics Group (FNCH), China SXT Pharmaceuticals (SXTC), and Ovid Therapeutics (OVID). These companies are all part of the "pharmaceutical products" industry. Incannex Healthcare vs. Its Competitors ABVC BioPharma NeuroSense Therapeutics CASI Pharmaceuticals KALA BIO Q32 Bio Enlivex Therapeutics X4 Pharmaceuticals Finch Therapeutics Group China SXT Pharmaceuticals Ovid Therapeutics Incannex Healthcare (NASDAQ:IXHL) and ABVC BioPharma (NASDAQ:ABVC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, community ranking, analyst recommendations, dividends, institutional ownership and media sentiment. Do institutionals & insiders believe in IXHL or ABVC? 0.4% of Incannex Healthcare shares are held by institutional investors. Comparatively, 11.4% of ABVC BioPharma shares are held by institutional investors. 15.5% of Incannex Healthcare shares are held by company insiders. Comparatively, 17.1% of ABVC BioPharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer IXHL or ABVC? Incannex Healthcare and ABVC BioPharma both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformIncannex HealthcareN/AN/AABVC BioPharmaN/AN/A Which has more risk and volatility, IXHL or ABVC? Incannex Healthcare has a beta of 7.63, indicating that its stock price is 663% more volatile than the S&P 500. Comparatively, ABVC BioPharma has a beta of 0.19, indicating that its stock price is 81% less volatile than the S&P 500. Which has better earnings & valuation, IXHL or ABVC? ABVC BioPharma has higher revenue and earnings than Incannex Healthcare. ABVC BioPharma is trading at a lower price-to-earnings ratio than Incannex Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIncannex Healthcare$98K70.16-$18.46M-$1.21-0.19ABVC BioPharma$508.38K61.80-$10.52M-$0.13-14.23 Is IXHL or ABVC more profitable? Incannex Healthcare has a net margin of 0.00% compared to ABVC BioPharma's net margin of -1,619.65%. ABVC BioPharma's return on equity of -104.94% beat Incannex Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Incannex HealthcareN/A -289.30% -154.96% ABVC BioPharma -1,619.65%-104.94%-56.81% Does the media prefer IXHL or ABVC? In the previous week, Incannex Healthcare had 1 more articles in the media than ABVC BioPharma. MarketBeat recorded 4 mentions for Incannex Healthcare and 3 mentions for ABVC BioPharma. ABVC BioPharma's average media sentiment score of 1.47 beat Incannex Healthcare's score of 0.96 indicating that ABVC BioPharma is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Incannex Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ABVC BioPharma 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryABVC BioPharma beats Incannex Healthcare on 8 of the 13 factors compared between the two stocks. Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IXHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXHL vs. The Competition Export to ExcelMetricIncannex HealthcarePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.88M$6.92B$5.61B$8.62BDividend YieldN/A2.55%5.28%4.18%P/E Ratio-0.178.6727.1419.96Price / Sales70.16262.53411.83157.63Price / CashN/A65.8538.2534.64Price / Book4.676.597.064.69Net Income-$18.46M$143.75M$3.23B$248.14M7 Day Performance30.50%3.72%2.67%2.39%1 Month PerformanceN/A11.01%8.82%6.05%1 Year Performance-92.79%3.87%31.44%13.60% Incannex Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXHLIncannex Healthcare0.8589 of 5 stars$0.23+16.8%N/A-93.9%$6.88M$98K-0.173Short Interest ↓Gap UpHigh Trading VolumeABVCABVC BioPharma0.5529 of 5 stars$1.54+12.4%N/A+96.5%$23.27M$508.38K-1.7930Positive NewsNRSNNeuroSense Therapeutics2.2182 of 5 stars$1.69+9.7%$14.00+728.4%+146.5%$23.10MN/A-2.6410CASICASI Pharmaceuticals4.392 of 5 stars$1.87-1.3%$4.00+114.5%-44.7%$22.94M$31.37M-0.84180KALAKALA BIO3.7903 of 5 stars$3.52-5.4%$13.50+283.5%-30.7%$22.71M$3.89M-0.2830Positive NewsGap UpQTTBQ32 Bio3.4341 of 5 stars$1.83+5.8%$24.71+1,250.5%-91.5%$22.32M-$6.65M-0.1339Positive NewsShort Interest ↓ENLVEnlivex Therapeutics3.4669 of 5 stars$0.94+0.4%$10.00+963.8%-33.7%$22.23MN/A-0.9670News CoverageUpcoming EarningsXFORX4 Pharmaceuticals4.3593 of 5 stars$3.81+12.1%$72.33+1,798.5%-89.8%$22.06M$31.36M-42.3380Short Interest ↑Analyst RevisionHigh Trading VolumeFNCHFinch Therapeutics Group0.3559 of 5 stars$13.60+0.7%N/A+885.6%$21.84M$110K-1.54190SXTCChina SXT Pharmaceuticals0.4897 of 5 stars$1.32-5.0%N/A-77.6%$20.89M$1.82M0.0090Short Interest ↑Gap DownOVIDOvid Therapeutics4.3753 of 5 stars$0.29+6.5%$2.78+860.1%-89.7%$20.62M$548K-0.6260News Coverage Related Companies and Tools Related Companies ABVC BioPharma Alternatives NeuroSense Therapeutics Alternatives CASI Pharmaceuticals Alternatives KALA BIO Alternatives Q32 Bio Alternatives Enlivex Therapeutics Alternatives X4 Pharmaceuticals Alternatives Finch Therapeutics Group Alternatives China SXT Pharmaceuticals Alternatives Ovid Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IXHL) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IXHL Stock Free IXHL Stock Alerts